Published peptide research references
RTD-1
Identity watchlist — review pending
3 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Approved source records
Preclinical Pharmacokinetics and Safety of Intravenous RTD-1.
Source identity and connection checked by Codex (AI).
RTD-1 therapeutically normalizes synovial gene signatures in rat autoimmune arthritis and suppresses proinflammatory mediators in RA synovial fibroblasts.
DOI: 10.1152/physiolgenomics.00066.2019
Source identity and connection checked by Codex (AI).
Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa.
Source identity and connection checked by Codex (AI).
Legacy research context
Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.
Researchers represented
- Tongaonkar P
- Punj V
- Subramanian A
- Tran DQ
- Trinh KK
- Schaal JB
- Laragione T
- Ouellette AJ
- Gulko PS
- Selsted ME
- Beringer PM
- Bensman TJ
- Ho H
- Agnello M
- Denovel N
- Nguyen A
- Wong-Beringer A
- She R
- Moskowitz SM
- Park AYJ
- Wang M